Related Experiment Video
Updated: Apr 12, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
27.9K
[A clinical study of fulminant amebic colitis]
Yoshihiro Mori1, Sadatoshi Shimizu, Yukio Nishiguchi
1Department of Gastroenterological Surgery, Osaka City General Hospital.
Summary
Fulminant amebic colitis is rare but deadly. Early diagnosis of amebic colitis is crucial for successful treatment, even with atypical symptoms, to improve patient outcomes.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Clinical Medicine
Background:
- Amebic colitis, commonly treated with metronidazole, can present with severe, fulminant forms.
- Fulminant amebic colitis is a rare condition with a high mortality rate.
- Diagnosis can be challenging due to atypical symptoms and lack of clear risk factors.
Observation:
- Three cases of fulminant amebic colitis were observed between 1993 and 2014.
- One patient succumbed to the illness despite medical intervention.
- The condition often lacks obvious preceding risk factors.
Findings:
- Amebic colitis frequently presents with non-specific clinical signs, complicating early identification.
- Early diagnosis is paramount for effective management of fulminant amebic colitis.
- The presented cases highlight diagnostic difficulties.
Implications:
- Clinicians should consider amebic colitis in patients presenting with acute abdomen.
- Prompt recognition and treatment are vital for improving survival rates in fulminant amebic colitis.
- Further research into early diagnostic markers may be warranted.
